CLINICAL_TRIALS
trial_result
· 2013-01-04
Clinical Trial Update: Safety Study of CDP7657 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus (SLE) [Phase 1]
Summary
A Phase 1 safety study of CDP7657 was conducted in healthy volunteers and patients with systemic lupus erythematosus. The trial status is Completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: UCB Pharma | Conditions: Immune System Diseases, Autoimmune Diseases | Phase 1 | Status: COMPLETED